Anti-Spike RBD Antibody (R16-F10) is a monoclonal antibody that is specificly targeting for the spike receptor binding domain of SARS-CoV-2. It is useful tool to estimate the individual protection against severe acute respiratory syndrome voronavirus 2 (SARS-CoV-2) infection. MW :150 KD.